Soaring Demand Set to Propel Heart Attack Diagnostic Market to $16.49 Billion by 2029

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Expected CAGR for the Heart Attack Diagnostic Market Through 2025?
The size of the market for diagnosing heart attacks has seen significant growth lately. It is projected to expand from $10.78 billion in 2024 to $11.62 billion in 2025, yielding a compound annual growth rate (CAGR) of 7.7%. The growth observed in the past period is tied to factors such as the creation of cardiac biomarkers, the introduction of ECG and imaging, the standardizing of diagnostic procedures, efforts to increase awareness and education, and enhancements in troponin testing.

What's the Projected Size of the Global Heart Attack Diagnostic Market by 2029?
The market size for heart attack diagnostics is set to witness robust expansion in the forthcoming years, soaring to $16.49 billion by 2029, with a compound annual growth rate (CAGR) of 9.2%. The anticipated growth during the forecast period can be associated with factors such as greater patient involvement and engagement, precision medicine supported by data analytics, the institution of preventive healthcare measures, the enhancement of healthcare infrastructure, and the adoption of tailored diagnostic methodologies. Key emerging trends in the projection period comprise of point-of-care testing, high-sensitivity troponin tests, non-invasive imaging techniques, individualized treatment, and remote patient monitoring devices.

View the full report here:
https://www.thebusinessresearchcompany.com/report/heart-attack-diagnostic-global-market-report

Top Growth Drivers in the Heart Attack Diagnostic Industry: What's Accelerating the Market?
The escalating occurrence of heart-related issues is advancing the heart attack diagnostics market. Cardiovascular diseases (CVD) are a collection of ailments that affect the heart and blood vessels. Unhealthy diet, physical inactivity, tobacco usage, and excessive alcohol consumption are primary contributors to heart diseases and stroke. Heart attack diagnostic technologies enable the exploration of causes and severity of heart attacks, strokes, and heart failure. For instance, statistics released by the Office for Health Improvement and Disparities, a government body in the UK, showed that in 2023, just over 1,862,500 individuals (representing 3%) were diagnosed with CHD by general practitioners in England. Consequently, the continuous rise in cardiovascular diseases will persist in propelling the growth of the heart attack diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8498&type=smp

What Trends Will Shape the Heart Attack Diagnostic Market Through 2029 and Beyond?
The heart diagnostic market is currently witnessing the evolution of innovative diagnostic methodologies specifically for heart ailments, which is a predominant trend. Notably, key market players are formulating novel methods such as the use of artificial intelligence to diagnose heart diseases. Artificial intelligence can be understood as the capability of devices to mimic human thought and behavioural processes. This technique is being adopted to enhance diagnostic radiography, expedite the diagnosis of heart issues, and implement faster treatment for strokes. As a case in point, in February 2022, the Smidt Heart Institute at Cedars-Sinai, an academic healthcare institution, crafted an AI-oriented technique to detect challenging cardiac conditions. This AI system has the ability to recognize disease patterns that may go unnoticed by the human eye and use these patterns to predict accurate diagnoses. Efficient detection and differentiation of potentially lethal disorders such as hypertrophic cardiomyopathy and cardiac amyloidosis have been made possible through the use of AI technology.

What Are the Main Segments in the Heart Attack Diagnostic Market?
The heart attack diagnostic market covered in this report is segmented -

1) By Test Type: Electrocardiogram (ECG Or EKG), Blood Tests, X-Ray, Echocardiogram, Coronary Catheterization (Angiogram), Exercise Stress Test, Magnetic Resonance Imaging (MRI)
2) By Procedure: Invasive Procedure, Non-Invasive Procedure
3) By End-Use Industry: Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Other End-Users

Subsegments:
1) By Electrocardiogram (ECG Or EKG): Resting ECG, Holter Monitor, Event Monitor
2) By Blood Tests: Cardiac Biomarkers, Lipid Panel, B-Type Natriuretic Peptide (BNP)
3) By X-Ray: Chest X-Ray, Angiography X-Ray
4) By Echocardiogram: Transthoracic Echocardiogram (TTE), Transesophageal Echocardiogram (TEE), Doppler Echocardiogram
5) By Coronary Catheterization (Angiogram): Coronary Angiography, Right Heart Catheterization, Left Heart Catheterization
6) By Exercise Stress Test: Treadmill Stress Test, Pharmacologic Stress Test, Nuclear Stress Test
7) By Magnetic Resonance Imaging (MRI): Cardiac MRI, Stress MRI, Perfusion MRI

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8498&type=smp

Which Top Companies are Driving Growth in the Heart Attack Diagnostic Market?
Major companies operating in the heart attack diagnostic market are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Hitachi Ltd., Koninklijke Philips NV, Midmark Corp., Siemens AG, Toshiba Corp., Welch Allyn Inc., HILL ROM HOLDINGS Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., Fujifilm Holdings, ACS Diagnostics Inc., Beckman Coulter Inc., Schiller AG, GE Healthcare, HeartFlow, Medtronic PLC, Cardio Diagnostics Holdings Inc., Becton Dickinson and Company, Danaher Corporation, Edwards Lifesciences Corporation, Johnson & Johnson, Quest Diagnostics, Roche Diagnostics, Thermo Fisher Scientific Inc.

Which Regions Will Dominate the Heart Attack Diagnostic Market Through 2029?
North America was the largest region in the heart attack diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8498

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.